PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 21, 2026Canadian Urological Association Journal0 citationsOpen Access

Incidental Prostate Cancer Rates Following HoLEP: Role of PSA Density

Rates of incidental prostate cancer following HoLEP

View Full Paper
Ask AI
Bookmark
Share

Authors

AÖAhmet Furkan ÖzsoyCACagri AkpinarMMMarko Maras

Discussion

Loading...

Member takes

Overview

Analysis finds that PSA density predicts incidental prostate cancer in older men, suggesting pre-surgical evaluations may be necessary.

Key Points

  • This research examines the preoperative factors associated with incidental prostate cancer following HoLEP surgery.
  • Analyzed preoperative data from patients undergoing HoLEP.
  • Evaluated the relationship between PSA density and incidence of prostate cancer.
  • Assessed the impact of age and total PSA levels on cancer detection.
  • PSA density was found to be an independent predictor of incidental prostate cancer.
  • Older age and higher total PSA levels were correlated with clinically significant cancer cases.
  • Recommendations suggest assessing high PSA density in older patients prior to hoLEP.

Cite This Study

Özsoy et al. (2026) studied this question.

synapsesocial.com/papers/69be35166e48c4981c6733achttps://doi.org/10.5489/cuaj.9444
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Hidden findings: How often does Holmium laser enucleation of the prostate (HoLEP) uncover prostate cancer?2025
  2. 2[Assessment of Incidental Prostate Carcinoma Cases and Predictors by Holmium Laser Enucleation of the Prostate].2024
  3. 3Incidental prostate cancer following surgery for benign prostatic hyperplasia: a cohort study.2026
  4. 4Integrating PSA Change with PSA Density Enhances Diagnostic Accuracy and Helps Avoid Unnecessary Prostate Biopsies2025 · 8 citations
  5. 5PROSTATE SPECIFIC ANTIGEN DENSITY AS A PREDICTOR FOR PROSTATE CANCER IN CASES WITH PROSTATE SPECIFIC ANTIGEN LEVELS GREATER THAN 4NG/ML2025